Aster DM Healthcare Limited has reported a robust performance for the second quarter of fiscal year 2026, demonstrating resilience and growth across its operations in India.

Financial Highlights

For Q2 FY26, Aster DM Healthcare posted:

• Revenue of INR 1,197.00 crores, up 10% year-over-year (YoY) and 11% quarter-on-quarter (QoQ)
• Operating EBITDA of INR 263.00 crores, increasing 13% YoY and 22% QoQ
• Operating EBITDA margin of 22.0%, compared to 21.4% in Q2 FY25 and 20.0% in Q1 FY26
• Normalized PAT (Post NCI) of INR 110.00 crores, growing 14% YoY and 23% QoQ

Operational Performance

The company witnessed significant improvements across various operational metrics:

• Average Revenue Per Patient (ARPP) for inpatients rose 10% YoY to INR 118,552.00
• Complex, Oncology, Neuro, Gastro, and Ortho (CONGO) mix increased by 240 basis points to 51%
• Total patient volume grew by 15% QoQ, with inpatient volume up 12% QoQ and outpatient volume rising 15% QoQ
• Overall occupancy improved to 64% from 59% in the previous quarter

Cluster-wise Performance

Kerala Cluster:

• Revenue grew 11% YoY to INR 620.00 crores
• Operating EBITDA margin expanded to 26.8% from 25.0% in Q2 FY25

Karnataka & Maharashtra Cluster:

• Revenue increased 10% YoY to INR 405.00 crores
• Operating EBITDA grew 6% YoY to INR 99.00 crores

Andhra & Telangana Cluster:

• Revenue rose 8% YoY to INR 135.00 crores
• Operating EBITDA margin stood at 13.2%, improving significantly from 7.9% in Q1 FY26

Strategic Developments

Aster DM Healthcare continues to expand its footprint and enhance its service offerings:

• Commenced operations of Aster MIMS Kasaragod, a 264-bed multispecialty hospital in Kerala, on October 2, 2025
• Acquired an additional 12.99% stake in Dr. Ramesh Cardiac and Multispeciality Hospital Private Limited, increasing its shareholding to 70.48%
• Received No Objection Letters from BSE and NSE for the proposed merger with Quality Care India Limited

Dr. Azad Moopen, Founder Chairman and Managing Director of Aster DM Healthcare, commented on the results: "Aster DM Healthcare delivered a steady performance in Q2 FY26, with revenue increasing 10% year-on-year to ₹1,197 crore despite lower incidence of seasonal illness. The Kerala cluster demonstrated a strong turnaround in FY26, emerging from last year's softness with renewed momentum and discipline."

The company's focus on expanding its hospital network, improving operational efficiencies, and enhancing its digital health initiatives positions it well for sustained growth in the Indian healthcare market.

Aster DM Healthcare , a leading integrated healthcare services provider, has reported a robust financial performance for the second quarter. The company's net profit saw a significant increase of 13.6% year-over-year, reaching 1.10 billion rupees compared to 968.40 million rupees in the same period last year.

Revenue Growth and Operational Performance

The company's revenue for Q2 showed a healthy growth of 10.2%, rising to 11.97 billion rupees from 10.86 billion rupees in the corresponding quarter of the previous year. This growth reflects Aster DM Healthcare's strong market position and effective operational strategies.

Improved Profitability Metrics

Aster DM Healthcare's profitability metrics also showed improvement:

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased by 13.6% to 2.50 billion rupees, up from 2.20 billion rupees in the previous year. The EBITDA margin also improved, rising to 20.87% from 20.23%, indicating enhanced operational efficiency.

Strategic Developments

During the quarter, Aster DM Healthcare made several strategic moves to strengthen its market position:

1. The company invested 50.01 crores in Aster DM Super Speciality Hospital (Sarjapur) Private Limited, a wholly-owned subsidiary.

2. Aster DM Healthcare entered into an agreement to lease a property in Yeshwantpur, Bengaluru, to establish its fifth multispecialty hospital in the city.

3. The company acquired an additional 12.99% stake in Dr. Ramesh Cardiac and Multispeciality Hospital Private Limited for 62.91 crores, increasing its shareholding from 57.49% to 70.48%.

4. A new wholly-owned subsidiary, Aster DM Super Speciality Hospital (Yeswanthpur) Private Limited, was incorporated.

Outlook

The company's consistent growth in revenue and profitability, coupled with its strategic expansions, positions Aster DM Healthcare well for continued success in the healthcare sector. The focus on establishing new hospitals and increasing stakes in existing facilities indicates a robust growth strategy aimed at capturing a larger market share in the competitive healthcare industry.